Cardiol Therapeutics (CRDL) Profit After Tax (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Profit After Tax came in at -$7.9 million in Q1 2026, down 36.59% YoY from -$12.4 million in Q1 2025, and down 52.53% on a QoQ basis from -$5.2 million in Q4 2025.
Cardiol Therapeutics (CRDL) Profit After Tax (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Profit After Tax data on file, last reported at -$7.9 million in Q1 2026.
- Quarterly Profit After Tax fell 36.59% year-over-year to -$7.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.3 million (down 100.49% YoY) and the FY2025 annual result came in at -$24.3 million, up 7.63% from the prior year.
- Profit After Tax retreated to -$7.9 million in Q1 2026, from -$5.2 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $9.3 million in Q3 2024 to a low of -$40.0 million in Q4 2022.
- A 5-year average of -$5.1 million and a median of -$5.1 million in 2022 frame the typical range for Profit After Tax.
- The widest YoY moves for Profit After Tax: up 310.93% in 2024, down 186.63% in 2024.
- Tracing CRDL's Profit After Tax over 5 years: stood at -$40.0 million in 2022, then advanced by 10.8% to -$35.7 million in 2023, then surged by 83.61% to -$5.9 million in 2024, then increased by 11.66% to -$5.2 million in 2025, then sank by 52.53% to -$7.9 million in 2026.
- The last three Profit After Tax figures came in at -$7.9 million (Q1 2026), -$5.2 million (Q4 2025), and -$7.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Cardiol Therapeutics | 212.63 Mn | 193.78 Mn | - | 4.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.89 Mn |
| Dec 31, 2025 | -5.17 Mn |
| Sep 30, 2025 | -7.24 Mn |
| Jun 30, 2025 | 6.03 Mn |
| Mar 31, 2025 | -5.78 Mn |
| Dec 31, 2024 | -5.85 Mn |
| Sep 30, 2024 | 9.33 Mn |
| Jun 30, 2024 | -4.82 Mn |
| Mar 31, 2024 | 6.81 Mn |
| Dec 31, 2023 | -35.71 Mn |
| Sep 30, 2023 | -4.42 Mn |
| Jun 30, 2023 | 5.56 Mn |
| Mar 31, 2023 | -5.24 Mn |
| Dec 31, 2022 | -40.04 Mn |
| Sep 30, 2022 | 6.11 Mn |
| Jun 30, 2022 | -5.09 Mn |
| Mar 31, 2022 | 7.07 Mn |
| Dec 31, 2021 | -45.24 Mn |
| Sep 30, 2021 | 7.87 Mn |
| Jun 30, 2021 | -5.34 Mn |